Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Eliem Therapeutics, Inc. (ELYM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
18.46+0.89 (+5.07%)
At close: 4:00PM EDT
18.46 0.00 (0.00%)
After hours: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close17.57
Open17.59
Bid13.00 x 800
Ask20.00 x 800
Day's Range17.31 - 18.92
52 Week Range13.51 - 29.69
Volume40,160
Avg. Volume230,196
Market Cap490.074M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-16.38
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est33.33
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ELYM

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Eliem Therapeutics, Inc
    Daily – Vickers Top Buyers & Sellers for 08/18/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more
  • TipRanks

    Buy These 3 New Stocks Before They Jump Over 60%, Say Analysts

    Stock markets have been rising steadily from their ‘corona trough’ in the spring of last year – that’s no secret, in fact, it’s been a huge boon for investors. Stocks have consistently shown the best returns, as central banks have been holding rates low. But there’s been an unintentional consequence of the stock boom, one that wasn’t foreseen but has given a boost to both companies and investors alike. The sustained gains in stocks has encouraged a surge in IPO activity. Companies are taking adv

  • GlobeNewswire

    Eliem Therapeutics Reports Second Quarter Financial Results

    On track to advance two clinical programs through five proof-of-concept trials and progress two preclinical programs over the next 18-24 months Recently completed an IPO for $92 million in gross proceeds that, along with existing cash, provides cash runway through late 2023 SEATTLE and CAMBRIDGE, United Kingdom, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc., a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address u

  • Benzinga

    Mid-Morning Market Update: Markets Open Lower; Empire State Manufacturing Index Dips In August

    Following the market opening Monday, the Dow traded down 0.40% to 35,372.03 while the NASDAQ fell 1.27% to 14,634.24. The S&P also fell, dropping 0.57% to 4,442.47. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 36,680,110 cases with around 621,630 deaths. India confirmed a total of at least 32,225,510 cases and 431,640 deaths, while Brazil reported over 20,364,090 COVID-19 cases with 569,050 deaths. In total, there were at least 207,273,290 ca

Advertisement
Advertisement